Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MU7N
|
|||
| Former ID |
DIB005244
|
|||
| Drug Name |
123I-MNI-330
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [1] | |
| Company |
Molecular Neuroimaging Llc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00657813) Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.